Search Results
Dr. Ingrid Mayer, USA
Dr Ingrid Mayer
Triple Negative Breast Cancer with Dr. Ingrid Mayer, Komen Scholar
Dr. Ingrid Mayer on Targeted Therapies in ER+ Breast Cancer
Breast Cancer Staging
Capecitabine remains the adjuvant standard of care for TNBC with residual disease | Ingrid Mayer
Updates in Breast Cancer - October 2020
Advancements in Estrogen Receptor–Positive Breast Cancer
Dr. Mayer on Toxicities Associated With Therapies for ER+ Breast Cancer
Virtual Research Panel - October 12, 2020
Overcoming Endocrine Resistance in Breast Cancer
Utilizing Molecular Testing to Guide Treatment Options in Breast Cancer